# Efficacy and Mechanism of FMT in the Treatment of Inflammatory Bowel Disease: an Open-label Randomized Controlled Study

> **NCT07149441** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Shanghai 10th People's Hospital** · enrollment: 94 (actual)

## Conditions studied

- Inflammatory Bowel Disease (Crohn&Amp;#39;s Disease and Ulcerative Colitis)
- Fecal Microbiota Transplantation

## Interventions

- **PROCEDURE:** Fecal microbiota transplantation
- **DRUG:** infliximab

## Key facts

- **NCT ID:** NCT07149441
- **Lead sponsor:** Shanghai 10th People's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-08-01
- **Primary completion:** 2028-09-01
- **Final completion:** 2028-09-01
- **Target enrollment:** 94 (ACTUAL)
- **Last updated:** 2025-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07149441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07149441, "Efficacy and Mechanism of FMT in the Treatment of Inflammatory Bowel Disease: an Open-label Randomized Controlled Study". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07149441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
